Ligand Pharmaceuticals Incorporated (LGNDZ)

OTCMKTS · Delayed Price · Currency is USD · Rights
0.0013
-0.0003 (-18.75%)
At close: May 29, 2026
Market Cap4.00B +78.9%
Revenue (ttm)268.09M +60.4%
Net Income124.45M
EPS6.13
Shares Out n/a
PE Ratio32.10
Forward PE21.17
Dividendn/a
Ex-Dividend Daten/a
Volume100,000
Open0.0013
Previous Close0.0016
Day's Range0.0013 - 0.0013
52-Week Range0.0013 - 0.0129
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 7, 2026

About Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteopor... [Read more]

Industry Pharmaceutical Preparations
Sector Healthcare
Founded 1987
Employees 47
Stock Exchange OTCMKTS
Ticker Symbol LGNDZ